Abstract
Hereditary motor and sensory neuropathy (HMSN) type IIA is caused by mutations in the mitofusin type-2 (MFN2) gene and represents one of the most common axonal forms of HMSN. We determined the spectrum and frequency of MFN2 gene mutations in patients from the Bashkortostan Republic (BR). Four different mutations were revealed in 5 out of 170 unrelated patients, i.e., c.2113G>A (p.Val705Ile) (1.2% among all types of HMSN in the total sample of patients and 2% among patients of Tatar ethnicity). This mutation was described previously; c.775C>T (p.Arg259Cys) (0.6%, in the total sample of patients and 2% among the patients of Tatar ethnicity); c.776G>A (p.Arg259His) (0.6% in the total sample of patients and 1.5% among the patients of Russians ethnicity); and c.2171T>C (p.Leu724Pro) (1.2% in the total sample of patients and 7.4% among the patients of Bashkirs ethnicity). These are new mutations that were not observed among healthy family members and in control samples of healthy subjects. Five identified nucleotide substitutions represent single nucleotide polymorphisms of the gene, including c.892G>A (p.Gly298Arg), c.957C>T (Gly319Gly), and c1039-222t>c, which were described previously, while c.175+28c>t and c.2204+15t>c represent new nucleotide substitutions in the intron regions of the gene.
Similar content being viewed by others
References
Harding, A.E. and Thomas, P.K., The clinical features of hereditary motor and sensory neuropathy types I and II, Brain, 1980, vol. 103, pp. 259–280.
Dyck, P.J., Chance, P., Lebo, R., and Carney, J.A., Hereditary motor and sensory neuropathies, Peripher. Neuropathy, 1993, vol. 2, pp. 1094–1136.
www.neuro.wustl.edu/neuromuscular/time/hmsn.html. Accessed July 01, 2012.
Skre, H., Genetic and clinical aspects of Charcot-Marie-Tooth’s disease, Clin. Genet., 1974, vol. 6, pp. 98–118.
Emery, A., Population frequency of inherited neuro-muscular diseases—a world survey, Neuromusc. Disord., 1991, vol. 1, pp. 19–29.
Ionasescu, V., Charcot-Marie-Tooth neuropathies: from clinical description to molecular genetics, Muscle Nerve, 1995, vol. 18, pp. 267–275.
Timmerman, V., Raeymaekers, P., and De Jonghe, P., Assignment of the Charcot-Marie-Tooth neuropathy type I (CMT 1A) gene to 17p11.2-P12, Am. J. Hum. Genet., 1990, vol. 47, pp. 680–685.
Patel, P.I., Franco, B., and Garcia, C., Genetic mapping of autosomal dominant Charcot-Marie-Tooth disease in a large french-acadian kindred: identification of new linked markers on chromosome 17, Am. J. Hum. Genet., 1990, vol. 46, pp. 801–809.
Lebo, R.V., Lynch, E.D., and Bird, T.D., Multicolor in situ hybridization and linkage analysis order Charcot-Marie-Tooth Type I (CMT 1A) Gene-Region Markers, Am. J. Hum. Genet., 1992, vol. 50, pp. 42–55.
Ionasescu, V., Lonasescu, R., and Searby, C., Screening for dominantly inherited Charcot-Marie-Tooth neuropathies, Muscle Nerve, 1993, vol. 16, pp. 1232–1238.
Nelis, E., Van Broeckhoven, C., Timmerman, V., et al., Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study, Eur. J. Hum. Genet., 1996, vol. 4, pp. 25–33.
Misk, A., Jiang, S., Wegorzewska, I., et al., Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex, J. Neurosci., 2010, vol. 30, no. 12, pp. 4232–4240.
Bach, D., Pich, S., Soriano, F.X., et al., Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism: a novel regulatory mechanism altered in obesity, J. Biol. Chem., 2003, vol. 278, pp. 17190–17197.
Eura, Y., Ishihara, N., Yokota, S., and Mihara, K., Two mitofusin proteins, mammalian homologues of FZO, with distinct functions are both required for mitochondrial fusion, J. Biochem. (Tokyo), 2003, vol. 134, pp. 333–344.
Rojo, M., Legros, F., Chateau, D., and Lombes, A., Membrane topology and mitochondrial targeting of mitofusins, ubiquitous mammalian homologs of the transmembrane GTPase Fzo, J. Cell Sci., 2002, vol. 115, pp. 1663–1674.
http://www.hgmd.org. Accessed July 01, 2012.
Shchagina, O.A., Dadali, E.L., Fedotov, V.P., and Polyakov, A.V., Mutations spectrum in MFN2 gene in patients with hereditary motor and sensory neuropathies type IIA, Med. Genet., 2006, vol. 129, pp. 2093–2102.
Verhoeven, K., Claeys, K.G., Zuchner, S., et al., MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth Type 2, Brain, 2006, vol. 129, pp. 2093–2102.
Züchner, S., Mersiyanova, I.V., Muglia, M., et al., Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A, Nat. Genet., 2004, vol. 36, pp. 449–451.
Krupina, N.B., Khidiyatova, I.M., Latypova, E.G., et al., Clinical epidemiological study of inherited motor and sensorial neuropathy and the screening for PMP22 gene duplications among patients in Republic of Bashkortostan, Med. Genet., 2006, no. 11, pp. 126–128.
Khidiyatova, I.M., Bagautdinova, E.G., Galieva, D.V., et al., Spectrum and frequency of mutations in the connexin 32 gene (GJB1) in hereditary and sensory neuropathy type 1X patients from Bashkortostan, Russ. J. Genet., 2008, vol. 44, no. 10, pp. 1201–1207.
Mathew, C.C., The isolation of high molecular weight eukaryotic DNA, Methods in Molecular Biology, Walker, J.M., Ed., New York: Human Press, 1984, vol. 2.
Lawson, V.H., Graham, B.V., and Flanigan, K.M., Clinical and electrophysiologic features of CMT2A with mutations in the mitofusin 2 gene, Neurology, 2005, vol. 65, pp. 197–204.
www.molgen.ua.ac.be/CMTMutations. Accessed July 01, 2012.
Engelfried, K., Vorgerd, M., Hagedorn, M., et al., Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2), BMC Med. Genet., 2006, vol. 8, pp. 7–53.
Braathen, G.J., Sand, J.C., Lobato, A., et al., MFN2 point mutations occur in 3.4% of Charcot-Marie-Tooth families: an investigation of 232 Norwegian CMT families, BMC Med. Genet., 2010, vol. 11, p. 48.
Kijima, K., Numakura, C., Izumino, H., et al., Mitochondrial GTPase mitofusin 2 mutation in Charcot-Marie-Tooth neuropathy type 2A, Hum. Genet., 2005, vol. 116, pp. 23–27.
Zhu, D., Kennerson, M.I., Walizada, G., et al., Charcot-Marie-Tooth with pyramidal signs is genetically heterogeneous: families with and without MFN2 mutations, Neurology, 2005, vol. 65, pp. 496–497.
Züchner, S., De Jonghe, P., Jordanova, A., et al., Axonal neuropathy with optic atrophy (HMSN VI) is caused by mutations in mitofusin 2, Ann. Neurol., 2006, vol. 59, pp. 276–281.
Lin, K.-P., Soong, B.-W., Yang, Ch.-Ch., et al., The mutational spectrum in a cohort of Charcot-Marie-Tooth disease type 2 among the Han Chinese in Taiwan, PLoS One, 2011, vol. 6, no. 12, pp. 1–9.
Shchagina, O.A., Dadali, E.L., and Fedotov, V.P., Clinical and genetic characteristics of hereditary motorsensory neuropathy type IIA, Ann. Neurol., 2007, vol. 1, no. 4, pp. 11–14.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © I.M. Khidiyatova, I.A. Skachkova, E.V. Saifullina, R.V. Magzhanov, O.A. Schagina, R.A. Zinchenko, A.N. Petrin, E.K. Khusnutdinova, 2013, published in Genetika, 2013, Vol. 49, No. 7, pp. 884–890.
Rights and permissions
About this article
Cite this article
Khidiyatova, I.M., Skachkova, I.A., Saifullina, E.V. et al. MFN2 gene analysis in patients with hereditary motor and sensory neuropathy from Bashkortostan Republic. Russ J Genet 49, 771–777 (2013). https://doi.org/10.1134/S1022795413060045
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1022795413060045